The tumor microenvironment: a milieu hindering and obstructing antitumor immune responses A Labani-Motlagh, M Ashja-Mahdavi, A Loskog Frontiers in immunology 11, 940, 2020 | 596 | 2020 |
Differential expression of ligands for NKG2D and DNAM-1 receptors by epithelial ovarian cancer-derived exosomes and its influence on NK cell cytotoxicity A Labani-Motlagh, P Israelsson, U Ottander, E Lundin, I Nagaev, ... Tumor Biology 37, 5455-5466, 2016 | 87 | 2016 |
Boosting CAR T-cell responses in lymphoma by simultaneous targeting of CD40/4-1BB using oncolytic viral gene therapy J Wenthe, S Naseri, A Labani-Motlagh, G Enblad, KI Wikström, E Eriksson, ... Cancer Immunology, Immunotherapy, 1-15, 2021 | 35 | 2021 |
Systemic immunity upon local oncolytic virotherapy armed with immunostimulatory genes may be supported by tumor-derived exosomes A Labani-Motlagh, S Naseri, J Wenthe, E Eriksson, A Loskog Molecular Therapy-Oncolytics 20, 508-518, 2021 | 30 | 2021 |
The role of NK and NKT cells in the pathogenesis and improvement of multiple sclerosis following disease‐modifying therapies A Ahmadi, Z Fallah Vastani, M Abounoori, M Azizi, A Labani‐Motlagh, ... Health Science Reports 5 (1), e489, 2022 | 13 | 2022 |
The tumor microenvironment: a milieu hindering and obstructing antitumor immune responses. Front Immunol. 2020; 11: 940 A Labani-Motlagh, M Ashja-Mahdavi, A Loskog External Resources Crossref (DOI), 2020 | 11 | 2020 |
Assessment of cytokine mRNA expression profiles in tumor microenvironment and peripheral blood mononuclear cells of patients with high-grade serous carcinoma of the ovary P Israelsson, A Labani-Motlagh, I Nagaev, E Dehlin, O Nagaeva, ... Journal of Cancer Science & Therapy 9 (5), 422-429, 2017 | 7 | 2017 |
Development of a human glioblastoma model using humanized DRAG mice for immunotherapy R Srivastava, A Labani-Motlagh, A Chen, JA Bohorquez, B Qin, M Dodda, ... Antibody Therapeutics 6 (4), 253-264, 2023 | 5 | 2023 |
Bacteriophage therapy for the treatment of Mycobacterium tuberculosis infections in humanized mice F Yang, A Labani-Motlagh, JA Bohorquez, JD Moreira, D Ansari, S Patel, ... Communications Biology 7 (1), 294, 2024 | 2 | 2024 |
Bacteriophage therapy for the treatment of Mycobacterium tuberculosis infections in humanized mice F Yang, A Labani-Motlagh, JD Moreira, D Ansari, JA Bohorquez, S Patel, ... bioRxiv, 2023.01. 23.525188, 2023 | 1 | 2023 |
Immunostimulatory gene therapy with an oncolytic virus expressing TMZ-CD40L and 4-1BBL induces oncolysis and show immunomodulatory capacity in soft tissue sarcoma A Calandigary, A Labani-Motlagh, D Tamindzic, T Lövgren, E Eriksson, ... Cancer Research 83 (7_Supplement), 695-695, 2023 | | 2023 |
Exosomes derived from tumor cells treated with immunostimulatory oncolytic virotherapy exert immune activation instead of immunosuppression A Labani-Motlagh, S Naseri, J Wenthe, E Eriksson, A Loskog Cancer Research 81 (13_Supplement), 1689-1689, 2021 | | 2021 |
P129 Assessment of cytokine mRNA expression profiles in tumor microenvironment and peripheral blood mononuclear cells of patients with high-grade serous carcinoma of the ovary P Israelsson, A Labani-Motlagh, I Nagaev, E Dehlin, O Nagaeva, ... International Journal of Gynecological Cancer 29 (Suppl 4), A138-A138, 2019 | | 2019 |
Assessment of cytokine mRNA expression profiles in tumor microenvironment and peripheral blood mononuclear cells of patients with high-grade serous carcinoma of the ovary P Israelsson, A Labani-Motlagh, I Nagaev, E Dehlin, O Nagaeva, ... International Journal of Gynecological Cancer 29, A138-A138, 2019 | | 2019 |
Nordic Obstetrics and Gynecology Theses January-June 2017 U Baker, A Baranov, L Bärebring, C Berger, L Bohr Mordhorst, CE Cesta, ... | | 2017 |
Immune modulation in serous epithelial ovarian cancer: focus on the role of tumor-derived exosomes A Labani Motlagh Umea University, 2017 | | 2017 |
Deregulated expression of lncRNAs in epithelial ovarian cancer tissue can be revealed by probing circulating exosomes: A possible novel approach to cancer diagnosis A Labani-Motlagh | | 2017 |